AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.9200
-0.0151 (-1.61%)
At close: Oct 8, 2025, 4:00 PM EDT
0.8903
-0.0297 (-3.23%)
After-hours: Oct 8, 2025, 6:53 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $10.71 million as of October 8, 2025. Its market cap has decreased by -59.49% in one year.
Market Cap
10.71M
Enterprise Value
18.82M
1-Year Change
-59.49%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $10.71M, a decrease of -83.17%. That is a compound annual growth rate of -32.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 10.89M | -49.56% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 763.90B |
| Johnson & Johnson | 457.13B |
| AbbVie | 410.76B |
| UnitedHealth Group | 335.10B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.88B |